Aqr Capital Management LLC Ani Pharmaceuticals Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 15,404 shares of ANIP stock, worth $868,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,404

Previous 17,527 12.11%

Holding current value

$868,169

Previous $1.12 Million 17.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$54.33 - $65.72 $115,342 - $139,523	-2,123 Reduced 12.11%	15,404 $919,000
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $317,174 - $372,935	5,419 Added 44.76%	17,527 $1.12 Million
Q1 2024 May 15, 2024	BUY	$54.2 - $69.69 $407,963 - $524,556	7,527 Added 164.31%	12,108 $837,000
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $223,186 - $299,734	4,581 New	4,581 $252,000
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $663,560 - $961,573	-28,738 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $566,670 - $992,884	21,058 Added 274.19%	28,738 $808,000
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $253,209 - $436,608	7,680 New	7,680 $354,000
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $517,472 - $703,316	-19,542 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$31.86 - $38.6 $40,589 - $49,176	-1,274 Reduced 6.12%	19,542 $685,000
Q1 2021 May 17, 2021	SELL	$28.4 - $36.14 $381,241 - $485,143	-13,424 Reduced 39.21%	20,816 $752,000
Q4 2020 Feb 16, 2021	SELL	$23.69 - $31.47 $97,010 - $128,869	-4,095 Reduced 10.68%	34,240 $994,000
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $444,001 - $557,106	-16,831 Reduced 30.51%	38,335 $1.08 Million
Q2 2020 Aug 17, 2020	SELL	$29.93 - $50.1 $157,012 - $262,824	-5,246 Reduced 8.68%	55,166 $1.78 Million
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $1.6 Million - $3.54 Million	52,740 Added 687.43%	60,412 $2.46 Million
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $167,729 - $240,607	3,014 Added 64.71%	7,672 $473,000
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $126,876 - $167,449	-1,961 Reduced 29.63%	4,658 $339,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $99,215 - $120,340	-1,464 Reduced 18.11%	6,619 $544,000
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $38,634 - $59,465	843 Added 11.64%	8,083 $570,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $105,065 - $144,034	-2,552 Reduced 26.06%	7,240 $326,000
Q3 2018 Nov 15, 2018	BUY	$52.95 - $71.34 $93,033 - $125,344	1,757 Added 21.87%	9,792 $554,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $99,961 - $120,705	-1,773 Reduced 18.08%	8,035 $537,000
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $558,859 - $710,197	9,808 New	9,808 $571,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Ani Pharmaceuticals Inc Transaction History